Bristol Enterprise Value Over E B I T D A from 2010 to 2024
| BMY Stock | USD 58.23 0.35 0.60% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 7.01243189 | Current Value 12.19 | Quarterly Volatility 10.16206921 |
Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.3 B, Interest Expense of 1.2 B or Selling General Administrative of 3.6 B, as well as many indicators such as Price To Sales Ratio of 2.98, Dividend Yield of 0.0374 or PTB Ratio of 6.92. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
Bristol | Enterprise Value Over E B I T D A |
Latest Bristol Myers' Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Bristol Myers Squibb over the last few years. It is Bristol Myers' Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bristol Myers' overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Bristol Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | 18.00 | |
| Geometric Mean | 15.63 | |
| Coefficient Of Variation | 56.47 | |
| Mean Deviation | 7.86 | |
| Median | 16.67 | |
| Standard Deviation | 10.16 | |
| Sample Variance | 103.27 | |
| Range | 33.4009 | |
| R-Value | (0.19) | |
| Mean Square Error | 107.07 | |
| R-Squared | 0.04 | |
| Significance | 0.49 | |
| Slope | (0.44) | |
| Total Sum of Squares | 1,446 |
Bristol Enterprise Value Over E B I T D A History
About Bristol Myers Financial Statements
Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 7.01 | 12.19 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bristol Stock Analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.